| in the pembrolizumab cohorts | 8 | other |
| a bit | 6 | degree |
| significantly | 5 | degree |
| grade → be → lower | 71 |
| grade → be → lower than those | 3 |
| negative | neutral | positive |
| 0.387 | 0.527 | 0.087 |
| Raw frequency | 74 |
| Normalized frequency | 0.660 |
| Modifier score | 0.400 |
| Perplexity | 458.179 |